JP2011246469A5 - - Google Patents

Download PDF

Info

Publication number
JP2011246469A5
JP2011246469A5 JP2011138647A JP2011138647A JP2011246469A5 JP 2011246469 A5 JP2011246469 A5 JP 2011246469A5 JP 2011138647 A JP2011138647 A JP 2011138647A JP 2011138647 A JP2011138647 A JP 2011138647A JP 2011246469 A5 JP2011246469 A5 JP 2011246469A5
Authority
JP
Japan
Prior art keywords
alkyl
pivaloyl
mesylate
benzoyl
hydrogen succinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011138647A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011246469A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011246469A publication Critical patent/JP2011246469A/ja
Publication of JP2011246469A5 publication Critical patent/JP2011246469A5/ja
Pending legal-status Critical Current

Links

JP2011138647A 1998-11-05 2011-06-22 B型肝炎ウイルス活性を持ったヌクレオシド Pending JP2011246469A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10711698P 1998-11-05 1998-11-05
US60/107,116 1998-11-05
US11565399P 1999-01-13 1999-01-13
US60/115,653 1999-01-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000579613A Division JP2002528554A (ja) 1998-11-05 1999-11-05 B型肝炎ウイルス活性を持ったヌクレオシド

Publications (2)

Publication Number Publication Date
JP2011246469A JP2011246469A (ja) 2011-12-08
JP2011246469A5 true JP2011246469A5 (enExample) 2012-09-06

Family

ID=26804401

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000579613A Withdrawn JP2002528554A (ja) 1998-11-05 1999-11-05 B型肝炎ウイルス活性を持ったヌクレオシド
JP2011138647A Pending JP2011246469A (ja) 1998-11-05 2011-06-22 B型肝炎ウイルス活性を持ったヌクレオシド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000579613A Withdrawn JP2002528554A (ja) 1998-11-05 1999-11-05 B型肝炎ウイルス活性を持ったヌクレオシド

Country Status (13)

Country Link
US (1) US6458773B1 (enExample)
EP (1) EP1124839B1 (enExample)
JP (2) JP2002528554A (enExample)
KR (1) KR100618028B1 (enExample)
CN (1) CN1216893C (enExample)
AT (1) ATE315574T1 (enExample)
AU (1) AU774720B2 (enExample)
BR (1) BR9915555A (enExample)
CA (1) CA2348470C (enExample)
DE (1) DE69929460D1 (enExample)
IL (2) IL142983A0 (enExample)
MX (1) MXPA01004504A (enExample)
WO (1) WO2000026225A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058686B1 (en) * 1998-02-25 2006-11-02 Emory University 2'-fluoronucleosides
PY0111577A (es) 2000-05-23 2017-01-02 Idenix Cayman Ltd Métodos y composiciones para el tratamiento del virus de la hepatitis c
AP2006003708A0 (en) 2000-05-26 2006-08-31 Idenix Cayman Ltd Methods and compositions for treating flavivirusesand pestiviruses
WO2002094844A2 (en) * 2001-05-18 2002-11-28 Rakesh Kumar Antiviral nucleosides
CN1678326A (zh) 2002-06-28 2005-10-05 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2'-c-甲基-3'-o-l-缬氨酸酯核糖呋喃基胞苷
US7608600B2 (en) * 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
US20040067877A1 (en) 2002-08-01 2004-04-08 Schinazi Raymond F. 2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections
EP1556398B1 (en) * 2002-10-31 2009-09-09 Metabasis Therapeutics, Inc. Novel cytarabine monophosphate prodrugs
RU2005118421A (ru) 2002-11-15 2006-01-20 Айденикс (Кайман) Лимитед (Ky) 2'-разветвленные нуклеозиды и мутация flaviviridae
PL377287A1 (pl) 2002-12-12 2006-01-23 Idenix (Cayman) Limited Sposób wytwarzania 2'-rozgałęzionych nukleozydów
JP5254033B2 (ja) 2005-12-23 2013-08-07 イデニク プハルマセウティカルス,インコーポレイテッド 分岐型ヌクレオシドを調製するための合成中間体の製造方法
US10449210B2 (en) 2014-02-13 2019-10-22 Ligand Pharmaceuticals Inc. Prodrug compounds and their uses
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
CN111788196A (zh) 2018-01-09 2020-10-16 配体药物公司 缩醛化合物及其治疗用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077279A (en) 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US4681933A (en) 1986-05-01 1987-07-21 University Of Georgia Research Foundation, Inc. 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US5084445A (en) 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
US4916122A (en) 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US5190926A (en) 1987-01-28 1993-03-02 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents
US5041449A (en) 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
NZ228645A (en) 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
DD293498A5 (de) 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
DE4224737A1 (de) 1992-07-27 1994-02-03 Herbert Prof Dr Schott Neue Cytosinnucleosidanaloga, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2637774C (en) * 1993-09-10 2011-07-19 Emory University Nucleosides with anti-hepatitis b virus activity
FR2709754B1 (fr) 1993-09-10 1995-12-01 Centre Nat Rech Scient Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
DE4418690A1 (de) 1994-05-28 1996-01-11 Boehringer Mannheim Gmbh Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
US5559101A (en) 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
US5703058A (en) 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
ATE346651T1 (de) 1995-06-07 2006-12-15 Univ Emory Nucleoside mit anti-hepatitis b virus wirksamkeit
ATE459361T1 (de) 1995-09-07 2010-03-15 Univ Georgia Therapeutische azidverbindungen
AU738170B2 (en) 1996-10-16 2001-09-13 Icn Pharmaceuticals, Inc. Monocyclic L-nucleosides, analogs and uses thereof

Similar Documents

Publication Publication Date Title
JP2013518107A5 (enExample)
JP2013508279A5 (enExample)
JP2017531038A5 (enExample)
ME02321B (me) Antivirusna jedinjenja
JP2013534248A5 (enExample)
JP2013542247A5 (enExample)
JP2015500843A5 (enExample)
CY1119880T1 (el) Παραγωγα πυρρολοπυριμιδινης για χρηση στη θεραπεια ιικων λοιμωξεων
JP2010529147A5 (enExample)
JP2012184234A5 (enExample)
JP2013509429A5 (enExample)
JP2011251968A5 (enExample)
JP2013537203A5 (enExample)
JP2013519645A5 (enExample)
JP2017523225A5 (enExample)
JP2013537423A5 (enExample)
JP2012144574A5 (enExample)
JP2007302689A5 (enExample)
JP2012255026A5 (enExample)
JP2015505296A5 (enExample)
JP2013512277A5 (enExample)
JP2011518833A5 (enExample)
JP2015051983A5 (enExample)
JP2011527299A5 (enExample)
JP2015521156A5 (enExample)